Three-dimensional culture of human meniscal cells: Extracellular matrix and proteoglycan production by Gruber, Helen E et al.
BioMed  Central
Page 1 of 7
(page number not for citation purposes)
BMC Biotechnology
Open Access Research article
Three-dimensional culture of human meniscal cells: Extracellular 
matrix and proteoglycan production
Helen E Gruber*1, David Mauerhan1, Yin Chow, Jane A Ingram1, H 
James Norton2, Edward N Hanley Jr1 and Yubo Sun1
Address: 1Department of Orthopaedic Surgery, Carolinas Medical Center, Charlotte, NC, USA and 2Department of Biostatistics, Carolinas Medical 
Center, Charlotte, NC, USA
Email: Helen E Gruber* - helen.gruber@carolinashealthcare.org; David Mauerhan - david.mauerhan@carolinashealthcare.org; 
Yin Chow - yin.chow@carolinashealthcare.org; Jane A Ingram - jane.ingram@carolinasheatlhcare.org; H 
James Norton - james.norton@carolinashealthcare.org; Edward N Hanley - edward.hanley@carolinashealthcare.org; 
Yubo Sun - yubo.sun@carolinashealthcare.org
* Corresponding author    
Abstract
Background: The meniscus is a complex tissue whose cell biology has only recently begun to be
explored. Published models rely upon initial culture in the presence of added growth factors. The
aim of this study was to test a three-dimensional (3D) collagen sponge microenvironment (without
added growth factors) for its ability to provide a microenvironment supportive for meniscal cell
extracellular matrix (ECM) production, and to test the responsiveness of cells cultured in this
manner to transforming growth factor-β (TGF-β).
Methods: Experimental studies were approved prospectively by the authors' Human Subjects
Institutional Review Board. Human meniscal cells were isolated from surgical specimens,
established in monolayer culture, seeded into a 3D scaffold, and cell morphology and extracellular
matrix components (ECM) evaluated either under control condition or with addition of TGF-β.
Outcome variables were evaluation of cultured cell morphology, quantitative measurement of total
sulfated proteoglycan production, and immunohistochemical study of the ECM components
chondroitin sulfate, keratan sulfate, and types I and II collagen.
Result and Conclusion: Meniscal cells attached well within the 3D microenvironment and
expanded with culture time. The 3D microenvironment was permissive for production of
chondroitin sulfate, types I and II collagen, and to a lesser degree keratan sulfate. This
microenvironment was also permissive for growth factor responsiveness, as indicated by a
significant increase in proteoglycan production when cells were exposed to TGF-β (2.48 μg/ml ±
1.00, mean ± S.D., vs control levels of 1.58 ± 0.79, p < 0.0001). Knowledge of how culture
microenvironments influence meniscal cell ECM production is important; the collagen sponge
culture methodology provides a useful in vitro tool for study of meniscal cell biology.
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Background
The meniscus of the knee is a complex dense fibrous bio-
logic structure with a design to provide both stability and
a shock-absorber function. Collagenous components of
the extracellular matrix (ECM) help provide tensile
strength, and proteoglycan ECM components contribute
to the shock absorber function. The meniscus contains
both a vascularized outer portion and an inner, avascular
region.
Appropriate function of the menisci are needed for nor-
mal knee biomechanical function. Aging and degenera-
tion of the menisci result in tears being a common knee
injury; 15% of all sports knee injuries involve the menis-
cus [1]. Initial meniscal injury causes patient pain and dis-
ability, and further meniscal damage and/or loss is
associated with degenerative joint changes ultimately
leading to osteoarthritis [2-4]. In spite of patient pain and
major health care costs involved with meniscal damage,
research on the biology of the meniscal cells and the
potential for tissue engineering applications for the
meniscus are relatively new fields of endeavor [5].
Arnoczky has summarized major issues related to menis-
cal repair using scaffolds and cells [6], noting that
although some preliminary data had been done using
meniscal fibrochondrocytes, fibroblasts, or synovial cells
to produce a fibrocartilaginous tissue, additional studies
were needed to characterize the cellular features and ECM
produced. Several of the biologic considerations involved
in creating a tissue engineered meniscus have also been
described by Arnoczky [7], who has summarized several
of the important cell carrier (or scaffold) features, includ-
ing support of cell proliferation and ECM production, dif-
fusion of nutrients, possible use as a carrier for cytokines,
and biomechanical considerations. The latter has been
addressed also by Setton et al [8]. Cell carrier materials
should also degrade at a rate similar to the cell deposition
rate of the ECM [9].
Tissue engineering approaches include the use of cells in
specific cell carrier constructs or scaffolds which can pro-
vide specific cellular microenvironments directing desired
cellular activities, including ECM production, cell prolif-
eration and activation of cell signaling pathways [10,11].
or allow delivery of bioactive molecules, proteins or drugs
[12,13].
In the present study, we primarily focus upon use of a col-
lagen sponge scaffold for 3D human meniscal cell culture.
Rodkey has illustrated previous use of a bovine collage
meniscus scaffold implanted in the medial meniscus of
the dog [7]. Our laboratory has also previously used such
a construct in autologous disc cell implantation in a small
rodent model and in other studies evaluating ECM depo-
sition by human disc cells [14-16].
In this work, we have a primary interest in the ability of
cultured human meniscus cells to attach and expand
within this carrier, and to produce collagens and prote-
oglycans between and around these 3D cultured cells.
Meniscal cell responsiveness to TGF-β was also investi-
gated.
Results
Meniscal cells grew well from the initial explant culture
and expanded well in monolayer culture. As shown in Fig-
ure 1, cells in early (non-confluent) stages had a fibrob-
last-like morphology in monolayer, with prominent long
cell processes extending from the cells.
An initial series of experiments assessed the utility of the
micromass culture method with human meniscal cells.
Figure 2 shows that the resulting cell pellet contained
abundant proteoglycans; proteoglycans are stained pink
in this figure. However, these micromass cultures were
delicate, technically difficult to feed and maintain, and
resulted in small specimens which were challenging to
examine with histologic methods. Therefore, we next
investigated a collagen sponge 3D microenvironment for
meniscal cell culture.
Low confluence human meniscus cells are spindle-shaped in  monolayer culture Figure 1
Low confluence human meniscus cells are spindle-
shaped in monolayer culture. Note long processes which 
extend from the cells. (Hoffman modulation contrast image; 
bar = 10 μm).BMC Biotechnology 2008, 8:54 http://www.biomedcentral.com/1472-6750/8/54
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Meniscal cells were studied from 11 subjects to investigate
cell behavior, ECM formation and to quantify proteogly-
can production in 3D collagen sponge culture. Specimens
of meniscal cells in this 3D construct were easily fed, han-
dled and processed for histologic examination. The study
population contained 7 males and 4 females; 7 medial
and 7 lateral meniscal cultures were assessed. Mean age
for the medial meniscal cell surgical patients was 65.2
years + 10.9 (7) (mean ± S.D. (n)), and for the lateral
meniscal cell surgical patients 67.2 + 6.5 (7). Mean menis-
cal grades did not differ between the lateral and medial
groups (3.5 ± 0.7 (7) vs 3.4 ± 0.5 (7), respectively).
Proteoglycan production in 3D culture over 14 days was
assessed with the DMB assay. Total proteoglycan values
(μg/ml ECM digest) did not differ between the lateral and
medial study populations (2.097 ± 0.214 (7) vs 2.369 ±
0.272 (7), respectively).
Meniscal cells attached well to the 3D sponge surface as
shown in Figure 3A. ECM produced by cells filled cavities
within the 3D sponge matrix and was present between
and around cells (Figure 3B). Along the margin of the
sponge, at the sponge-media interface, cells formed a
boundary layer which often consisted of several layers of
cells (Figure 3C).
We next examined the response of human meniscal cells
in 3D sponge culture during exposure to 5 ng/ml TGF-β.
This portion of our study utilized meniscal cells derived
form 7 lateral and 8 medial menisci from 9 subjects (8
females, 1 male). Mean subject age was 64.6 years ± 8.5
(9). Cells were derived from three grade 3 menisci, and 12
grade 4 menisci. Results were analyzed in terms of quan-
titative assessment of total proteoglycan production by
control vs TGF-β-treated cells, and by immunohistologic
examination of ECM components.
Exposure to TGF-β significantly increased proteoglycan
production by cells in 3D sponge culture. TGF-β-treated
cells had a mean proteoglycan level of 2.48 ± 1.00 (15),
(mean ± S.D. (n), whereas the mean paired control level
was 1.58 ± 0.79 (15), p < 0.0001. Cells cultured in the
presence of TGF-β showed normal morphology and good
proliferation (Figure 4A and 4B).
Immunohistochemical studies were performed to evalu-
ate in vitro 3D production of selected major ECM compo-
nents: keratan sulfate, chondroitin sulfate, and types I and
II collagens. For keratan sulfate, localization was primarily
cytoplasmic, with scant keratan present in the ECM (data
not shown). In contrast, chondroitin sulfate was abun-
Histologic images of human meniscus cells cultured under  control conditions in the 3D collagen sponge Figure 3
Histologic images of human meniscus cells cultured 
under control conditions in the 3D collagen sponge. 
A. Arrows show good attachment of cells to the sponge sur-
face. B. * denotes concentration of ECM. C. Margin shows a 
tight layer of cells along the perimeter of the sponge. (Paraf-
fin embedded toluidine-blue stained specimens; for all images, 
bar = 50 μm).
Histologic images of two micromass cultures formed by  human meniscus cells Figure 2
Histologic images of two micromass cultures formed 
by human meniscus cells. Note the presence of ECM rich 
in proteoglycans as indicated by the pink stain. (Paraffin-
embedded micromass nodule, stained with toluidine blue; bar 
= 50 μm).BMC Biotechnology 2008, 8:54 http://www.biomedcentral.com/1472-6750/8/54
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dant in ECM surrounding cells in both control and TGF-
β-treated meniscal cells (Figure 5A and 5B). Abundant
type I collagen was seen in ECM under control culture
conditions (Figure 5C); type I production was also exten-
sive in the ECM of TGF-β-treated meniscal cells (Figure
5D). Although control cultures produced substantial
amounts of type II collagen (Figure 5E), ECM formed by
TGF-β-treated cells appeared to have qualitatively greater
amounts (Figure 5F).
Discussion
In this study we have shown that cells from even lower
grades of menisci with greater degeneration can be estab-
lished in culture, expanded and passaged, and studied in
3D culture microenvironments. It is interesting to note
that meniscal cells derived from one of our study subjects
with a grade 0 meniscus (i.e. a healthy meniscus) yielded
a proteoglycan production value not different from the
study population means for the lateral and medial cells
(2.421 μg/ml compared to the lateral mean of 2.097 and
medial mean of 2.369). We have also tested cells from a
12 year old child with an osteosarcoma, again with a
meniscal grade 0; this individuals proteoglycan produc-
tion level in 3D culture was also similar to the study
means (2.758). Thus, although our study has the short-
coming of utilizing primarily more degenerated menisci
with grades 3–5, we have a small body of evidence that the
3D collagen sponge methodology works well with menis-
cal cells from both health and degenerated menisci.
Although several other recent tissue culture studies that
have utilized other 3D methodologies, several have fea-
tures which make those methods more difficult to use in
experimental studies. Adesida et al. utilized a micromass-
like methodology, but this required that the culture be
carried out with supplemented chondrogenic factors
(insulin, transferrin, selenite, dexamethasone, TGF-β)
[17,18]. Such media additives should be kept in mind
when evaluating the resulting cell phenotype.
Other meniscal cell culture methodologies include the
gelatin hydrogel system utilized by Ishida et al. [19]and
polyglycolic acid scaffolds as utilized by Stewart et al. [20],
Marsano et al. [21], and Kang et al. [22]. The polyclycolic
carrier systems are complicated by the acidic microenvi-
ronment associated with their degradation, and long-last-
ing presence of macrophages/giant cells during this
process [23]. Previous work by Verdonk et al. utilized a
more traditional alginate culture methodology, but histo-
logic illustrations showed little ECM surrounding cells
[24].
Our study presents data on a relatively small patient pop-
ulation. It is important that future additional work
address cells derived from both medial and lateral menis-
cal sites, and that studies measure proteoglycan produc-
tion at additional time points which will expand our data
from 7 days of culture in micromass and 14 days of cul-
ture in 3D collagen sponges.
Because of the clinical importance of meniscal tears and
meniscal degeneration, we hope that culture methods
such as those described here will be used in future studies
of meniscal cell gene expression and tissue engineering
applications.
Conclusion
The present findings on ECM production under control
conditions by human meniscal cells provides an impor-
tant advance over routine monolayer cell culture. The 3D
microenvironment provides cues to the cells in a fashion
that is more like the in vivo condition of cells. Our studies
here utilized 20% fetal bovine serum to accelerate prolif-
Histologic features of human meniscal cells cultured in 3D  collagen sponge in the presence of TGF-β Figure 4
Histologic features of human meniscal cells cultured 
in 3D collagen sponge in the presence of TGF-β. A, 
note the high cell density; B, note accumulations of ECM 
marked by *. (Paraffin embedded sections stained with toluid-
ine blue; for both images, bar = 50 μm).BMC Biotechnology 2008, 8:54 http://www.biomedcentral.com/1472-6750/8/54
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eration and thus lessen the time cells were kept in monol-
ayer culture prior to experimental use. Although
micromass culture did show ECM production, this tech-
nique is extremely tedious and limited in analytical stud-
ies. The collagen sponge, in contrast, is easily
manipulated, does not require use of specialized chondro-
genic media to allow ECM production, provides ample
room for meniscal cell expansion and ECM production,
and is easily embedded for morphologic studies.
Methods
(i) Clinical Study Population
Experimental studies were approved prospectively by the
authors' Human Subjects Institutional Review Board.
Meniscal specimens were obtained from osteoarthritis
patients undergoing total joint replacement surgery and
transported immediately to the laboratory from the surgi-
cal suite. All the meniscal specimens obtained from oste-
oarthritis patients displayed clear signs of severe
fibrillation and tears (grades 3 and 4). One meniscal spec-
imen with normal-appearance (grade 0) was used in this
study from a patient undergoing meniscectomy due to
injury caused by an auto accident. Menisci were scored
according to the following scale: grade 0, normal; grade 1,
minimal fibrillation; grade 2, moderate fibrillation but
without tears; grade 3, severe fibrillation and the presence
of incomplete tears; grade 4, severe fibrillation with com-
plete tears or multiple incomplete tears.
(ii) Monolayer cell culture
Meniscal cells were isolated from surgical specimens as
previously described for the intervertebral disc using
explant techniques [25] and expanded in monolayer cul-
ture for experimental use. Cells were cultured in sterile
modified Minimal Essential Media with Earle's salts
(MEM; Gibco, Grand Island, NY) with L-glutamine 1% (v/
v) (Irvine Scientific, Santa Ana, CA), nonessential amino
acids 1% (v/v) (Irvine Scientific), penicillin-streptomycin
1% (Irvine Scientific) and fetal bovine serum 20%
(Gibco). All cultures were grown at 37°C under condi-
tions of 95% relative humidity and 5% CO2. Cells were
fed with fresh media 3 times a week.
(iii) Standardized Design for 3D Sponge Cell Culture 
Experiments
Cells were P2 or 3 when used in experiments. Sterile Gel-
foam®  (Pharmacia & Upjohn Co., Kalamazoo, MI)
sponges, an absorbable gelatin sponge prepared from
Immunolocalization of major ECM components in control and TGF-β-treated meniscal cells in 3D culture Figure 5
Immunolocalization of major ECM components in control and TGF-β-treated meniscal cells in 3D culture. The 
top row presents images from control cells; the second row presents images for TGF-β-treated cells. Chondroitin sulfate (CS): 
A: control cells show modest CS content in the ECM. B: ECM formed by TGF-β-treated cells shows more abundant CS com-
pared to controls. Type I collagen (Col type I) is abundant in both ECM formed by control (C) and TGF-β-treated cells (D). 
Type II collagen (Col type II): Control cells produced less type II collagen (E) when compared to ECM from TGF-β-treated cells 
(F). Figure 5G presents a representative negative control specimen. (For all images, bar in G = 50 μm).BMC Biotechnology 2008, 8:54 http://www.biomedcentral.com/1472-6750/8/54
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purified porcine skins gelatin USP granules, were trimmed
into 0.5 cm3 cubes. Following preliminary studies testing
cell concentrations, the work reported here used cell sus-
pensions containing an average of 100,000 cells in Mini-
mal Essential Medium with 20% fetal bovine serum
(MEM20); this concentration was injected into each
sponge cube with a pipette. Replicate collagen sponges
were placed on Costar Transwell Clear Inserts (Costar) in
24-well plates and soaked with 2 ml MEM20. Seeded con-
structs were placed in the incubator (37°C, 5% CO2, 95%
humidity) and fed with fresh media 3 times a week. The
TGF-β studies were carried out on cells cultured in 3D for
14 days with or without the addition of 5 ng/ml TGF-β
(Sigma, St. Louis, MO). At the end of the 14 day period,
replicate specimens were assessed either with histology
and immunohistochemistry or for quantitative analysis of
proteoglycan content (see below).
(iv) Micromass 3D Culture
Meniscal cells were also grown in micromass culture using
modifications of Tare et al [26] and Paulsen and Solursh
[27]. 200,000 cells were used to form each micromass cul-
ture. Micromass cultures were fed as described above and
terminated after 7 days of culture. Upon termination, the
micromass cultures were carefully transferred to a micro-
centrifuge tube, spun, and embedded in 1% sea plaque
agarose to facilitate subsequent specimen handling.
Micromasses were fixed in 10% neutral buffered formalin
for 1 hour, placed in 70% ethanol, and processed for par-
affin embedding.
(v) Morphologic and Immunohistochemical Analyses
At termination of culture, specimens were fixed in 10%
neutral buffered formalin (Allegiance, McGaw Park, IL)
for one hour and then transferred to 70% ethyl alcohol
(AAPER, Shelbyville, KY) and processed in paraffin using
a Shandon Pathcentre Automated Tissue Processor (Ther-
moShandon, Pittsburgh, PA). Specimens were embedded
in Paraplast Plus (ThermoShandon) paraffin and 4 μm
serial sections were cut with a Leica (Nussloch, Germany)
RM2025 microtome. Sections were mounted on Super-
frost-Plus microscope slides (Allegiance) and stained with
toluidine blue for routine study, or were utilized for
immunohistochemistry.
Immunohistochemistry
Collagen sponges were bisected and the two halves
embedded on edge. Specimens were embedded in Para-
plast Plus paraffin (ThermoShandon), and 4 mm serial
sections cut with a Leica (Nussloch, Germany) RM2025
microtome and mounted on Superfrost-Plus microscope
slides (Allegiance). Immunohistochemical localization of
types I and II collagen, chondroitin sulfate, decorin and
keratan sulfate utilized antibodies used techniques
described previously [15,25]. The following antibodies
were used at the indicated concentrations: anti-types I and
II collagen (Biodesign International, Kennebunk, ME), 20
μg/ml; anti-keratan sulfate (Seikagaku Corporation,
Tokyo, Japan), 5 μg/ml; anti-chondroitin sulfate (ICN
Biomedicals, Costa Mesa, CA), 20 μg/ml. Endogenous
peroxidase was blocked using 3% H202 (Humco, Texar-
cana, TX). The secondary antibody was Dako LSAB2 bioti-
nylated Link for HRP/AP for 10 minutes followed by
peroxidase-conjugated streptavidin (Dako) for 10 min-
utes and DAB (Dako) for 5 minutes. Slides were counter-
stained with light green, dehydrated, cleared and
mounted with resinous mounting media. Negative con-
trols consisted of Rabbit IgG (Dako, Carpinteria, CA, for
collagen I and II) or mouse IgG (Dako, Carpinteria, CA,
for all other antibodies) used at the same concentration as
each antibody.
(vi) Biochemical total glycosaminoglycan determination
The 1,9 dimethylmethylene blue (DMB) assay was uti-
lized to assess S-GAG production with modifications of
the previously described method [28]. The DMB (Aldrich,
Milwaukee, WI) solution was prepared and stored at
room temperature in an amber bottle. Collagen sponge
constructs containing cells were rinsed 3 times in Hanks
Balanced Salt Solution, HBSS, (Gibco, Carlsbad, CA).
Replicates were combined in 1.5 ml microcentrifuge tubes
and collagenase type V (Sigma) in HBSS (Gibco) was
added to produce a final concentration of 1.0 Units/ml.
The microcentrifuge tubes were incubated at 37°C until
the sponge was completely digested (15–30 minutes).
Samples were assayed in duplicate by mixing 0.1 ml of
sample with 1.25 ml DMB solution. For standards, 0 – 7.5
μg chondroitin sulfate (Sigma, St. Louis, MO) was added
to 1.25 ml DMB solution. All tubes were incubated at
room temperature in the dark for 30 minutes followed by
centrifugation at room temperature for 15 minutes at
10,000 rpm. One ml of the supernatant was removed and
the absorbency read at 595 nm using a Beckman DU 600
spectrophotometer (Fullerton, CA). Formate buffer, pH
3.1, was used as a blank. Sample concentrations were
determined from the standard curve and results expressed
as μg S-GAG/ml.
(vii) Statistical analysis
Statistical analysis utilized standard methods using SAS
software (version 8.2; SAS Institute, Cary, NC). Methods
used included paired t-tests and Pearson correlation statis-
tics. A p-value of less than 0.05 was considered statistically
significant.
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3D: three-dimensional; ECM: extracellular matrix; TGF-β:
transforming growth factor-beta; v: volume; MEM: Mini-
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